Literature DB >> 19843866

Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.

Chizu Tanikawa1, Koji Ueda, Hidewaki Nakagawa, Nobuaki Yoshida, Yusuke Nakamura, Koichi Matsuda.   

Abstract

Upon a wide range of cellular stresses, p53 is activated and inhibits malignant transformation through the transcriptional regulation of its target genes related to apoptosis, cell cycle arrest, and DNA repair. However, its involvement in posttranslational modifications of proteins has not yet been well characterized. Here, we report the novel role of p53 in the regulation of protein citrullination. p53 transactivated peptidylarginine deiminase type 4 (PADI4) through an intronic p53-binding site. The PADI4 gene encodes an enzyme catalyzing the citrullination of arginine residues in proteins, and ectopic expression of p53 or PADI4 induced protein citrullination. In addition, various proteins were citrullinated in response to DNA damage, but knockdown of PADI4 or p53 remarkably inhibited their citrullination, indicating the regulation of protein citrullination in a p53/PADI4-dependent manner. We found that PADI4 citrullinated the histone chaperone protein, nucleophosmin (NPM1), at the arginine 197 residue in vivo under physiologic conditions. Citrullination of NPM1 by PADI4 resulted in its translocation from the nucleoli to the nucleoplasm, whereas PADI4 did not alter the localization of mutant NPM1 (R197K). Furthermore, ectopic expression of PADI4 inhibited tumor cell growth, and concordantly, the knockdown of PADI4 attenuated p53-mediated growth-inhibitory activity, demonstrating the significance of PADI4-mediated protein citrullination in the p53 signaling pathway

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843866     DOI: 10.1158/0008-5472.CAN-09-2280

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

Review 1.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

2.  In silico prediction of physical protein interactions and characterization of interactome orphans.

Authors:  Max Kotlyar; Chiara Pastrello; Flavia Pivetta; Alessandra Lo Sardo; Christian Cumbaa; Han Li; Taline Naranian; Yun Niu; Zhiyong Ding; Fatemeh Vafaee; Fiona Broackes-Carter; Julia Petschnigg; Gordon B Mills; Andrea Jurisicova; Igor Stagljar; Roberta Maestro; Igor Jurisica
Journal:  Nat Methods       Date:  2014-11-17       Impact factor: 28.547

3.  Inhibiting protein arginine deiminases has antioxidant consequences.

Authors:  Erin E Witalison; Xiangli Cui; Anne B Hofseth; Venkataraman Subramanian; Corey P Causey; Paul R Thompson; Lorne J Hofseth
Journal:  J Pharmacol Exp Ther       Date:  2015-01-29       Impact factor: 4.030

4.  B-cell specific Moloney leukemia virus insert site 1 and peptidyl arginine deiminase IV positively regulate carcinogenesis and progression of esophageal squamous cell carcinoma.

Authors:  Wei Wang; Huai-Jun Ji; Ning-Bo Sun; Xiao-Tian Chang; Bing Xu; Yao Wang; Ming Cao; Qiang Zhu; Qi Zang; Zhong-Min Jiang
Journal:  Oncol Lett       Date:  2017-04-06       Impact factor: 2.967

5.  A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population.

Authors:  Chizu Tanikawa; Yuji Urabe; Keitaro Matsuo; Michiaki Kubo; Atsushi Takahashi; Hidemi Ito; Kazuo Tajima; Naoyuki Kamatani; Yusuke Nakamura; Koichi Matsuda
Journal:  Nat Genet       Date:  2012-03-04       Impact factor: 38.330

6.  PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.

Authors:  Hao Qin; Xiaoqiu Liu; Fujun Li; Lixia Miao; Tingting Li; Boqun Xu; Xiaofei An; Aaron Muth; Paul R Thompson; Scott A Coonrod; Xuesen Zhang
Journal:  Cancer Lett       Date:  2017-08-24       Impact factor: 8.679

7.  CLCA2 as a p53-inducible senescence mediator.

Authors:  Chizu Tanikawa; Hidewaki Nakagawa; Yoichi Furukawa; Yusuke Nakamura; Koichi Matsuda
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

8.  Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.

Authors:  Yuji Wang; Pingxin Li; Shu Wang; Jing Hu; Xiangyun Amy Chen; Jianhui Wu; Megan Fisher; Kira Oshaben; Na Zhao; Ying Gu; Dong Wang; Gong Chen; Yanming Wang
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

9.  PADI4 and tumourigenesis.

Authors:  Xiaotian Chang; Kehua Fang
Journal:  Cancer Cell Int       Date:  2010-03-12       Impact factor: 5.722

Review 10.  Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Authors:  Pamela Mangat; Natalia Wegner; Patrick J Venables; Jan Potempa
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.